Ronald Blue Trust, Inc. Ark Genomic Revolution ETF (De Transaction History
Ronald Blue Trust, Inc.
- $8.7 Billion
- Q3 2025
A detailed history of Ronald Blue Trust, Inc. transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 32 shares of ARKG stock, worth $860. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32Holding current value
$860% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding ARKG
# of Institutions
297Shares Held
20.3MCall Options Held
2.53MPut Options Held
2.8M-
Jpmorgan Chase & CO New York, NY3.94MShares$106 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.83MShares$76.2 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.16MShares$58.1 Million0.01% of portfolio
-
Citigroup Inc1.52MShares$40.8 Million0.02% of portfolio
-
Ubs Group Ag1.12MShares$30.1 Million0.01% of portfolio